medigraphic.com

2001, Número 2

<< Anterior Siguiente >>

Med Sur 2001; 8 (2)


Hepatitis C y diabetes mellitus

Sánchez ÁJF, Hernández LVJ, González HMS, Poo RJL, Uribe M

Idioma: Español
Referencias bibliográficas: 35
Paginas: 60-64
Archivo PDF: 42.22 Kb.


RESUMEN

La infección crónica por el virus de la hepatitis C (VHC) es una de las principales causas de hepatopatía en el mundo. En esta revisión se comenta la información obtenida en la literatura en relación a la asociación entre diabetes mellitus tipo 2 y hepatitis crónica viral C. Los estudios publicados recientemente han demostrado que la presencia de anticuerpos anti-VHC en diabéticos varía del 4 al 28%, en tanto que en los sujetos con hepatitis crónica C la prevalencia de diabetes puede llegar a ser hasta del 50%. Sin embargo, el papel del virus C en la generación de trastornos en el metabolismo de los carbohidratos no está definido ni sus implicaciones a largo plazo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clinics in Liver Disease 1997; 1: 559-569.

  2. Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis 1994; 15: 5-114.

  3. Alter MJ, Hadler SC, Judson FN et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C infection. JAMA 1990; 264: 2231-2235.

  4. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N Eng1 J Med 1992; 327: 1899-1905.

  5. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 67: 671.

  6. Agnello VV, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Eng J Med 1992; 327: 1889-905.

  7. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C et al. Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 1998; 27: 1661-9.

  8. Strassburg CP, Obermayer-Straub P, Manns MP. Autoimmunity in hepatitis C and D virus infection. J Viral hepatitis 1996; 3: 49-59.

  9. Tran A, Quaranta JF, Benzaken S, Thiers VV, Chau HT, Hastier P et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18: 253-7.

  10. Petrides AS, DeFronzo RA. Glucose metabolism in cirrhosis: A review with some perspectives for the future. Diabetes Metab Rev 1989; 5: 691-709.

  11. Proietto J, Alford FP, Dudley FJ. The mechanism of the carbohidrate intolerance in cirrhosis. J Clin Metab 1980; 51: 1030-6.

  12. Kruszynska YT, Home PD, Mc Intre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 1991; 14: 103-11.

  13. Nolte W, Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabetes 1995; 103: 63-74.

  14. Gray H, Wreghitt T, Straton N, Alexander GJ, Turner RC, O’Rahilly S. High prevalence of hepatitis C infection in afro-caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 1995; 12: 244-9.

  15. Simó R, Hernández C, Genescá J, Jardí R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19: 998-1000.

  16. Mason AL, Lau JYN, Hoang N, Keping Q, Alexander GJM et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.

  17. Allison ME, Wreghitt T, Palmer CR, Alexander GJM. Evidence for link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.

  18. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J et al. Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.

  19. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or colestatic disease.

  20. Mangia A, Schiavone G, Lezzi G, Marmo R, Bruno F, Villani MR et al. HCV and diabetes mellitus: evidence for a negative association. Am J gastroenterol 1998; 93: 2363-7.

  21. Del Olmo JA, serra MA, Rodrigo JM. Liver cirrhosis and diabetes mellitus. J Hepatol 1996; 24: 645.

  22. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355-9.

  23. Bigam DL, Pennington JJ, Carpentier A, Wanless IR, Hemming AW, Croxford R et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000; 32: 87-90.

  24. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szk1o M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Int Med 2000; 133: 592-9.

  25. Graeme A. An association between hepatitis C virus infection and type 2 diabetes mellitus: what is the connection? Ann Int Med 2000; 133: 650-52.

  26. Everhart J. A confluence of epidemics: Does hepatitis C cause type 2 diabetes? Hepatology 2001; 33: 762-3.

  27. Mehta SH, Brancati FL, Sulkowski MS, Strathdee S, Szk1o M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Hepatology 2001; 33: 820.

  28. Forrest JM, Menser MA, Burges JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971; 2: 332-4.

  29. Karjalainen J, Knip M, Hyoty H et al. Relationship between serum autoantibodies, islet cell antibodies, and coxsackie B-4 and mumps virus specific antibodies at the clinical manifestation of type 1 diabetes. Diabetología 1988; 1: 397-9.

  30. Pak CY, Eun HM, Mc Arthur RG et al. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988; 21-4.

  31. Gowans EJ. Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis 2000: 20: 85-102.

  32. Grimbert S, Valensi P, Levy-Marchal C, Perret G, Richardet JP, Raffoux C et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case control study. Gastroenterol Clin Biol 1996; 20: 544-8.

  33. Chem JPS, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD, F Ch-Ch. Abnormal glucose tolerance in transfusion-dependent B-thalassemic patients. Diabetes Care 2001; 24: 850-4.

  34. Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J et al. Evaluation of factor controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon alfa. Eur J Clin Invest 2000; 30: 111-21.

  35. Fujite H, Yotsuyanagi H, Moriya K, Shintani Y, Tsutsumi T, Takayama T et al. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J Med Virol 1999; 59: 141-5.




2020     |     www.medigraphic.com